Health Care/Hospital

BENDIT Technologies Receives U.S. Food and Drug Administration 510(k) Clearance of its Bendit 021" steerable microcatheter

TEL AVIV, Israel, April 19, 2022 /PRNewswire/ -- BENDIT Technologies , a company focused on the development of a steerable microcatheter platform, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bendit21 microcath...

2022-04-19 08:00 1680

Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases

* New data on COVID-19 Influenza combination vaccine and seasonal influenza vaccine to be presented at World Vaccine Congress * Several abstracts and presentations slated to highlight updates on NVX-CoV2373, Novavax' COVID-19 vaccine GAITHERSBURG, Md., April 18, 2022 /PRNewswire/ -- Novavax...

2022-04-18 22:13 2672

WHO report highlights the role of Traditional Chinese Medicine in the treatment of COVID-19

BEIJING, April 18, 2022 /PRNewswire/ -- A news report by haiwainet.cn: On March 31, World Health Organization released the meeting report of "WHO Expert Meeting on Evaluation of Traditional Chinese Medicine (TCM) in the Treatment of COVID-19" on its official website. The report acknowledged that ...

2022-04-18 15:18 1851

Illumina Singapore Jumps the Ranks to Earn Two Significant Spots in Singapore's Best Employers Award

The Annual Singapore's Best Employers survey is sponsored by The Straits Times and marketing firm, Statista. SINGAPORE, April 18, 2022 /PRNewswire/ -- Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) was honoured today to be ranked #17 overall and #1 in Healthcare Equipment & Servic...

2022-04-18 12:00 2622

World Hemophilia Day 2022 - "Access for All: Partnership. Policy. Progress. Engaging your government, integrating inherited bleeding disorders into national policy"

MONTREAL, April 17, 2022 /PRNewswire/ -- April 17, 2022 is World Hemophilia Day. The theme of the event this year is"Access for All: Partnership. Policy. Progress. Engaging your government, integrating inherited bleeding disorders into national policy". This important event is about bringing the ...

2022-04-17 17:00 2646

SonoScape receives FDA 510(k) clearance for HD-550 Endoscopy system

SHENZHEN, China, April 15, 2022 /PRNewswire/ -- On April 15th, SonoScape today announced that the U.S. Food and Drug Administration (FDA) has approved its flagship video endoscopy system HD-550 for gastrointestinal diagnosis, setting up a major milestone on SonoScape's Endoscopic product roadmap....

2022-04-15 17:11 5392

Venus Medtech Obtains CE Certification for VenusP-Valve™

HANGZHOU, China, April 15, 2022 /PRNewswire/ -- On April 8th, a Chinese company named Venus Medtech announced that its self-developed VenusP-Valve™ Percutaneous prosthetic pulmonary valve replacement system was approved by the European Union (CE) for marketing. This shows that VenusP-Valve™  meet...

2022-04-15 16:15 3053

Canton Fair 2022: Technological Innovation Steers Medical Industry Towards Golden Age

GUANGZHOU, China, April 14, 2022 /PRNewswire/ -- The 131st Canton Fair is open fromApril 15 to April 24. The Health section at the 131st Canton Fair is fully prepared in the expectation of a plenty of orders, as it attracted much attention from global buyers in the last session.Maggie Pu, Deputy ...

2022-04-14 22:04 2914

Clarin.com: Here are the 12 Argentinian doctors and researchers making the biggest international impact

BUENOS AIRES, Argentina, April 14, 2022 /PRNewswire/ -- The work of Argentine doctors and researchers is impacting other parts of the world. The research and analysis carried out by the firm Key Opinion Leaders and available athttps://www.keyopinionleaders.com/

2022-04-14 21:21 2273

DEBIOPHARM ANNOUNCES ONCOLOGY RESEARCH ADVANCEMENTS AT AACR 2022 FOR NOVEL CANCER COMPOUNDS AND DRUG DELIVERY TECHNOLOGIES

Pre-clinical & clinical exploratory poster presentations to highlight oncology results with Debio 0123, xevinapant, and Multilink™ technology for antibody drug conjugates LAUSANNE, Switzerland, April 14, 2022 /PRNewswire/ -- Debiopharm, ( www.debiopharm.com/debiopharm-international/

2022-04-14 21:20 2465

CDD Vault Integrates with SnapGene Server for Web-Based Sharing of Plasmid Information

BURLINGAME, Calif. and SAN DIEGO, April 14, 2022 /PRNewswire/ -- Collaborative Drug Discovery, Inc. (CDD) announced today that it has completed the integration of SnapGene Server with its flagshipCDD Vault research informatics platform. This integration allows users to visualize and share plasmid...

2022-04-14 20:45 2233

First Patients Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent

Physicians in Indiana, New York City, and Washington are among the first to administer Illuccix® – demonstrating coast-to-coast availability of this new imaging agent Typically diagnosed in men over 50, prostate cancer is the second leading cause of cancer death in American men, after lung cance...

2022-04-14 19:00 2216

International Team Led by BGI Completes First Whole-Body Cell Atlas of a Non-Human Primate

The research will provide insights into the development of potential treatments for neurological diseases and obesity, among other human conditions. SHENZHEN, China, April 14, 2022 /PRNewswire/ -- In a breakthrough that could lead to scientific advancement in the treatment of human diseases, rese...

2022-04-14 16:43 2184

International Team Led by BGI Completes First Whole-Body Cell Atlas of a Non-Human Primate

The research will provide insights into the development of potential treatments for neurological diseases and obesity, among other human conditions. SHENZHEN, China, April 14, 2022 /PRNewswire/ -- In a breakthrough that could lead to scientific advancement in the treatment of human diseases, rese...

2022-04-14 16:30 1691

Innovent Receives NMPA Breakthrough Designation for IBI310, the Anti-CTLA-4 Monoclonal Antibody, Combined with Sintilimab in Advanced Cervical Cancer Treatment

SAN FRANCISCO and SUZHOU, China, April 14, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other majo...

2022-04-14 08:30 5195

TauRx's late-stage clinical trial reaches new milestone

- Significant milestone in the only late-stage clinical trial targeting tau pathology of Alzheimer's - TauRx on track to announce top line results in May - Trial aims to confirm efficacy of first tau-based treatment for Alzheimer's ABERDEEN, Scotland and SINGAPORE, April 14, 2022 /PRNewswire/ -...

2022-04-14 08:17 1764

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW004, an oral tablet formulation of its Proprietary GLP-1 Analogue (Ecnoglutide)

HANGZHOU, China and SAN FRANCISCO, April 14, 2022 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, today announced the initiation of subject dosing in its Phase 1 clinic...

2022-04-14 08:00 1781

Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality Target to IND-enabling Studies for Various Oncological Disorders

Insilico Medicine Nominates Its USP1 Small Molecule Inhibitor as a Preclinical Candidate for Tumors with Homologous Recombination Deficiency NEW YORK, April 13, 2022 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery com...

2022-04-13 23:00 2744

LIMACORPORATE ANNOUNCES LEADERSHIP TRANSITION AND APPOINTMENT OF INTERIM CEO

UDINE, Italy, April 13, 2022 /PRNewswire/ -- LimaCorporate S.p.A., a leading global orthopedic manufacturer focused on digital innovation and tailored hardware, today announces thatLuigi Ferrari, Chief Executive Officer of LimaCorporate, will be stepping down from the role of CEO, to pursue new ...

2022-04-13 22:10 2403

European Wellness Signs MOU in Dubai Expo 2020 to Strengthen Medical Tourism into Malaysia and Develop Advanced Biological Regenerative Medicine in UAE

DUBAI, UAE, April 13, 2022 /PRNewswire/ -- European Wellness Biomedical Group (EW Group), through its Malaysian subsidiary European Wellness Academie, and Dubai- based healthcare distribution and technology group, AK International LLC, have signed a Memorandum of Understanding (MOU) on 30th March ...

2022-04-13 21:38 2805
1 ... 209210211212213214215 ... 553